The Medical Device User Fee and Modernization Act (MDUFA) authorizes the Center for Devices and Radiological Health (CDRH) to collect user fees from medical device manufacturers.[1] It is reauthorized every 5 years.[1]
In the years preceding enactment of MDUFMA, the FDA's medical device program suffered a long-term, significant loss of resources that undermined the program's capacity and performance.[2]
History
Medical Device User Fee and Modernization Act legislative history[1]
Year
Act
Legislative package
Synopsis
2002
MDUFA
Authorized FDA to collect fees for premarket review
2007
MDUFA II
FDA Amendments Act of 2007
Added two types of annual fees: establishment registration fee and product fee
2012
MDUFA III
Safety and Innovation Act of 2012
Expanded the definition of establishments subject to a registration fee, thus increasing the applicable device establishments paying the fee.
2017
MDUFA IV
FDA Reauthorization Act of 2017
Advanced the use of real-world evidence and patient engagement
2022
MDUFA V
Continuing Appropriations and Ukraine Supplemental Appropriations Act